Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
10m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
36m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
36m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
36m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
37m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Sangamo Therapeutics Inc logo

Sangamo Therapeutics Inc

About

Sangamo Therapeutics Inc (NASDAQ:SGMO) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 30 2026
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
Mar 19 2026
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
Mar 9 2026
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
Feb 3 2026
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026
Feb 3 2026
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering

Financials

Revenue
$39.55 M
Market Cap
$124.32 M
EPS
-0.44

Community Chat

Ask AI

6ix6ixAIEvents